Wellbeing Digital Sciences Inc. (KONEF)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Dec 16, 2025
KONEF Revenue
In the fiscal year ending July 31, 2022, Wellbeing Digital Sciences had annual revenue of 6.44M CAD with 469.43% growth. Wellbeing Digital Sciences had revenue of 1.16M in the quarter ending July 31, 2022, with 2.60% growth.
Revenue
6.44M CAD
Revenue Growth
+469.43%
P/S Ratio
0.00
Revenue / Employee
n/a
Employees
n/a
Market Cap
163.00 USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jul 31, 2022 | 6.44M | 5.31M | 469.43% |
| Jul 31, 2021 | 1.13M | - | - |
| Jul 31, 2020 | - | - | - |
| Jul 31, 2019 | - | - | - |
| Jul 31, 2018 | - | - | - |
| Jul 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nobilis Health | 282.58M |
| New York Health Care | 45.78M |
| Skylight Health Group | 39.37M |
| LifeHOUSE Holdings, LLC | 17.32M |
| Patient Portal Technologies | 13.23M |
| WellQuest Medical & Wellness | 4.09M |
| ER Urgent Care Holdings | 2.11M |
| Bionik Laboratories | 1.81M |
Wellbeing Digital Sciences News
- 2 years ago - Wellbeing Digital Subsidiary KGK Science to Participate at the Mushroom Summit and Psychedelic Science Conference - Business Wire
- 2 years ago - Wellbeing Digital Enters into Share Purchase Agreement with Cardinal Group - Business Wire
- 2 years ago - Wellbeing Digital Subsidiary KGK Science to Participate at the Nutrition Industry Association Spring Conference - Business Wire
- 2 years ago - Wellbeing Subsidiary KGK Science Announces Successful Results of UP360, a Nutraceutical Ingredient Demonstrating Beneficial Immune Defense Response - Business Wire
- 3 years ago - Wellbeing Subsidiary KGK Science Begins Recruitment in First-of-its-Kind Health Canada Approved Psilocybin Trial - Business Wire
- 3 years ago - Wellbeing Subsidiary KGK Science Receives Institutional Review Board Approval - Business Wire
- 3 years ago - Wellbeing Announces Cease Trade Order - Business Wire
- 3 years ago - Wellbeing Provides Bi-Weekly Default Status Report - Business Wire